Amyopathic dermatomyositis: a review
- PMID: 8423381
- DOI: 10.1111/1523-1747.ep12356896
Amyopathic dermatomyositis: a review
Abstract
Jim Gilliam's research interests throughout his career were forced upon better defining the relationships that exist between the cutaneous and systemic manifestations of the rheumatic diseases. Although the majority of his time was spent studying such relationships in lupus erythematosus patients, he was also intensely interested in dermatomyositis (DM) in this regard as well. He was particularly intrigued with the dissociation of the cutaneous and muscular manifestations of this disorder that occasionally occurs. The term "dermatomyositis siné myositis" has been used in the past to describe patients who present with only the cutaneous manifestations of DM; however, very little published data is available from systematic examinations of such patients. For several reasons, we have preferred the term "amyopathic dermatomyositis" to describe that rare patient who for long periods of time suffers from the classical skin lesions of DM as the only clinically significant manifestation of their disease. In this presentation, we review our own personal experience with a group of six such patients and compare and contrast it to that of other workers who have dealt with this subject over the past two decades.
Similar articles
-
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23. J Am Acad Dermatol. 2006. PMID: 16546580 Review.
-
A systematic review of juvenile-onset clinically amyopathic dermatomyositis.Br J Dermatol. 2007 Oct;157(4):637-44. doi: 10.1111/j.1365-2133.2007.08055.x. Epub 2007 Jun 26. Br J Dermatol. 2007. PMID: 17596148 Review.
-
Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.Paediatr Drugs. 2010;12(1):23-34. doi: 10.2165/10899380-000000000-00000. Paediatr Drugs. 2010. PMID: 20034339 Review.
-
Clinical characteristics and management of clinically amyopathic juvenile dermatomyositis across four academic centers.Pediatr Dermatol. 2021 Mar;38(2):413-419. doi: 10.1111/pde.14510. Epub 2021 Jan 13. Pediatr Dermatol. 2021. PMID: 33438772
-
[Dermatomyositis. Clinico-histologic study of its skin manifestations].Rev Med Univ Navarra. 1989 Jul-Sep;33(3):135-47. Rev Med Univ Navarra. 1989. PMID: 2489261 Review. Spanish.
Cited by
-
Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation.Cureus. 2022 Aug 10;14(8):e27839. doi: 10.7759/cureus.27839. eCollection 2022 Aug. Cureus. 2022. PMID: 36106216 Free PMC article.
-
Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department.Front Med (Lausanne). 2021 Dec 2;8:783416. doi: 10.3389/fmed.2021.783416. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34926528 Free PMC article.
-
TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features.J Transl Med. 2020 Mar 12;18(1):125. doi: 10.1186/s12967-020-02290-3. J Transl Med. 2020. PMID: 32164729 Free PMC article.
-
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis.Arthritis Res Ther. 2018 Oct 26;20(1):240. doi: 10.1186/s13075-018-1737-2. Arthritis Res Ther. 2018. PMID: 30367666 Free PMC article.
-
Classification of myositis.Nat Rev Rheumatol. 2018 May;14(5):269-278. doi: 10.1038/nrrheum.2018.41. Epub 2018 Apr 12. Nat Rev Rheumatol. 2018. PMID: 29651121 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
